JNJ-64841829 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
97潰瘍性大腸炎1

97. 潰瘍性大腸炎


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2021-001280-24-LT
(EUCTR)
07/12/202119/08/2021Study of VE202 in Patients with Ulcerative ColitisRandomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Mild-to-moderate ulcerative colitis (UC)
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: VE202
Product Code: VE202
INN or Proposed INN: Not applicable
Other descriptive name: JNJ-64841829
INN or Proposed INN: Not applicable
Other descriptive name: JNJ-64841842
INN or Proposed INN: Not applicable
Other descriptive name: JNJ-64841855
INN or Proposed INN: Not applicable
Other descriptive name: JNJ-64841894
INN or Proposed INN: Not applicable
Other descriptive name: JNJ-64841907
INN or Proposed INN: Not applicable
Other descriptive name: JNJ-64841920
INN or Proposed INN: Not applicable
Other descriptive name: JNJ-64841933
INN or Proposed INN: Not applicable
Other descriptive name: JNJ-64841946
Vedanta Biosciences, Inc.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
100Phase 2Serbia;United States;Czechia;Hungary;Poland;Ukraine;Lithuania;Bulgaria;Netherlands;United Kingdom